Before 2020, SPACs, or Special Purpose Acquisition Companies, were considered to be high-risk investments due to a lack of financial history and a variety of challenges that the companies face to comply with the SEC after they start trading. However, we have seen a lot of renewed interest in SPACs.... |
Good MorningThe major indices wobbled a bit in early trading on Tuesday but soon stabilized and began moving higher. The move was supported by comments from Fed Chief Jerome Powell and Secretary of the Treasury Steven Mnuchin in testimony to Congress. The two say the economy is rebounding despite obvious risks and stand ready to add support as needed.
The S&P 500 advanced more than 1.20% by the end of the day but the tech-heavy NASDAQ Composite led the session. The index appears to be putting in a bottom after the rout in FAANG names that brought it down to correction levels. With the third-quarter earnings season at hand, the odds of a deeper correction are getting hard to judge. This week's reports from Nike, Costco, and Carmax will dominate the market’s attention, any signs of strength or weakness are sure to spur investor activity.
Featured: One stock… 357% gains… Same date every year (Investpub (Wealthpress campaigns)) 
| Stocks | | |
Before 2020, SPACs, or Special Purpose Acquisition Companies, were considered to be high-risk investments due to a lack of financial history and a variety of challenges that the companies face to comply with the SEC after they start trading. However, we have seen a lot of renewed interest in SPACs... Read the Full Story |
| | Markets | | | This Is Why You Should Buy General Mills
General Mills (NYSE:GIS) has a few things going for it that make it a Buy before it reports earnings later this week. Among them are its positioning as a safe-haven consumer staples brand, its outlook for revenue, the value, and the dividend. The recent pull... Read the Full Story |
| Stocks | | | A 1,200% run in less than a month back in 2018 put shares of Tilray (NASDAQ: TLRY) firmly on the map for all the right reasons. The Canadian pharmaceutical and cannabis company had just IPO’d and was riding the wave of legalization which was sweeping across North America. But as the old saying... Read the Full Story |
| From Our PartnersLook out gold! Palladium just obliterated the all-critical $2,000 per ounce level, signaling an unprecedented wealth-building opportunity in select palladium stocks. Currently undiscovered and trading below $0.50 per share, this under-the-radar palladium company has the drills turning on what industry insiders are already calling the largest undeveloped palladium project in all of North America. | | More details here... |
| Markets | | | Edge cloud content delivery network Fastly, Inc. (NASDAQ: FSLY) shares sold off with the S&P 500 index (NYSEARCA: SPY) during the Q1 2020 pandemic plunge but managed to transcend its pre-COVID highs in May accelerating to all-time highs of $117.79 highs into Q2 earnings. The stay-at-home mandate... Read the Full Story |
| Markets | | | Peloton (NASDAQ: PTON) has been getting a lot of press since the onset of the pandemic, with its $2,000+ bikes flying off the shelves. 24 Hour Fitness and Gold’s Gym have filed for Chapter 11 bankruptcy. It is against this backdrop that Planet Fitness (NYSE: PLNT) stock has emerged a... Read the Full Story |
| From Our PartnersThere's an all-new way to trade - before the bell rings on Wall Street - allowing traders to achieve up to 1,139% return.
“Since I’ve started, I’m already up $46,5000” - A first user
Two hedge fund managers teamed up for an all-new strategy allowing YOU to trade outside of the competition.
If you know only two key numbers before the open then you could achieve up to 93.2% accuracy.
With average investors panic selling, it makes it even EASIER to spot.
This is your chance at a breakthrough trading strategy.
Click HERE to for the #1 Pre-Market strategy now.
| | | | Continue Reading |
| The Early Bird Stock Of The Day Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. | | View Today's Stock Pick |
|
| |
|
|
